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Abstract
The incidence of infection by Hepatitis A virus shows regional variation being highest in developing countries. Determination of age specific Hepatitis A virus (HAV)
seroprevalence and the associated risk factors would help better plan for national
preventive strategies including vaccination. We carried out a cross-sectional study on
300 children from Nairobi city, Kenya during the years 2003-2004. The age range of
the children was 2 - 14 years and were from low and high socioeconomic status (SES)
families. The indicators of SES included employment status, residence, number of
children per patient’s household, parents’ level of education and source of drinking
water. SES was encoded and analysed using Statistical Program for Social Sciences
(SSPS) version 16.0. Seroprevalence increased significantly with advancing age. Seropositivity of HAV antibodies was significantly higher among children of low SES,
77.6% by the age of 14 years compared to children of high SES, 38.9% by the same
age. Crowded household and parental education were significantly associated with
high seropositivity and seronegativity respectively. There is significant rate of seronegativity amongst the studied population especially those from richer backgrounds
making them more susceptible to severe infection in future with concomitant complications. We propose that revision of national vaccination program should be considered to include Hepatitis A vaccination.
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1. Introduction
The infection due to Hepatitis A virus (HAV) is on epidemiological transition globally
DOI: 10.4236/ojped.2016.64043
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with changing patterns in respect with economic fortunes. Certain regions of the world
are known to have the highest endemicity including Asia, Africa and parts of the Caribbean, South, Central America. Economic factors leading to high endemic levels include lack of proper housing and water sanitation, overcrowding and poverty [1] [2].
The virus is transmitted via the feco-oral route and its exact impact is always underestimated due to mildly symptomatic or asymptomatic nature of the infection [3] [4].
There is considerable variation in the rates of seroprevalence by region, country and
intra-country with marked fluctuations from time to time but in general the underdeveloped countries bear the greatest disease burden amongst children at an earlier age.
Coincidentally, these infections are mild to asymptomatic and most of the children attain immunity by the time they reach adolescence [5]. On the contrary, developed
countries are characterized by low antibody seroprevalence of HAV during childhood
which continues to adulthood where roughly 50% of the adult population is seronegative and consequently at risk of severe forms of hepatitis A infection [6] [7].
With improving economic fortunes of most developing nations, the epidemiologic
pattern of HAV is expected to shift and may demonstrate patterns similar to those of
developed countries. This has the potential of putting the adult population at risk of
severe hepatitis A infection [8]. Although Hepatitis A virus infection can easily and effectively be mitigated through vaccination [9], this has not been fully implemented and
included in the national vaccination programs of many countries including Kenya. As a
result, there is likelihood of witnessing more adult morbidity and mortality resulting
from HAV infection. This study aimed at determining the age specific HAV antibody
seroprevalence and the associated risk factors which would help better plan for national
preventive strategies including vaccination.

2. Patients and Methods
Three hundred children from Nairobi, Kenya aged between two and fourteen years
without a history of vaccination against hepatitis A, signs of hepatitis or jaundice and
had lived in the present accommodation or similar one in Nairobi from birth were included in the study. This study was done between year 2003 and 2004 in Nairobi City,
Kenya. Three hundred children were included in this study but only 256 were analysed.
The sample size was calculated based on prevalence of previous studies and considering
80% power. The children were subdivided into three age groups: 2 - 4, 5 - 9, 10 - 14
years.
Permission to carry out the study was obtained from Kenyatta National Hospital/
University of Nairobi Ethics and Review committee and the Aga Khan University Hospital Education committee. Informed consent obtained from the parents before the
children were included in the study. A structured questionnaire developed by the principal investigator in this study and his team was used to collectd emographic data and
evaluate the socioeconomic status (SES) of the subjects after pilot and proper validation
of the tools. The indicators of SES included employment status, residence, number of
children per patient’s household, parents’ level of education, source of drinking water.
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Socioeconomic status (SES) was encoded and scored as summarized in Table 1: Each
attribute was assigned 1 or 2 point(s) in column 1 and 2 respectively. Total score was
then calculated. A score of 6 or less was deemed as high SES while a score of 7 - 12 was
judged as low SES.
Alongside the questionnaire, 2 mL of blood was drawn from each patient by venous
puncture through a sterile procedure and collected into a vacutainer tube. Whole blood
was centrifuged at 3000 rpm for 15 minutes to obtain a serum sample which was then
stored in cryotubes at −20˚C within 24 hours of sampling. Enzyme-linked immunosorbent assay (ELISA; HAVAB-EIA; Abbot Diagnostics, Illinois, USA) was used to determine the presence of HAV antibodies.
Data obtained were entered and analyzed using SPSS version 16.0 Chicago Illinois.
Student t test was used for comparing qualitative variables. Logistic regression analysis
was performed to determine the SES factors associated with anti-HAV antibodies positivity. P values <0.05 were considered statistically significant.

3. Results
Out of the 300 children, 256 were analyzed while forty four were excluded for not
meeting the inclusion criteria. All the children were of African descent and boys were
slightly more than girls (137 boys, 119 girls). The overall HAV antibodyseroprevalence
in this population was 44.5%. The age distribution is shown in Table 2.
There were 189 children from low SES and 107 from high SES with varied distribution as shown on Figure 1.
Table 1. Risk factor attributes for hepatitis A virus.
1

2

Type of house

Permanent

Semi permanent or Shanty

Water supply

Running tap in the house

Running tap outside or communal
well/river/from a vendor

Sanitation

Flush toilet in the house

Communal flush toilet or pit latrine
outside or no defined facility

Low crowded house (1 - 4 people)

High crowded house (4 - 9 people)

Parents level of
education

Both parents with secondary
education and above

1 or 2 parents with primary education
or none

Parents income

High >$15 a day

Low <$3 a day

Crowded household

1 = High SES, 2 = Low SES.

Table 2. Distribution of children according to age group.
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Age group

Number

Percentage

2-4

80

31.3

5-9

109

42.6

10 - 14

67

26.2

Total

256

100

A. Wasunna et al.

When age specific seroprevalence of HAV antibodies were analyzed against socioeconomic status, it was found that generally children from a higher socioeconomic state
had low antibody seroprevalence (Table 3).
On subjecting variables of SES to logistic regression analysis, it was shown that factors associated with presence of HAV antibodies were related to age, crowding, parents
income, residential area, source of water supply and parent’s level of education level in
a descending order (Table 4).

Figure 1. Distribution of children by age groups and socioeconomic states.
Table 3. Age specific antibody seroprevalence of HAV.
Age group
2-4
5-9
10 - 14

Socioeconomic status

% seroprevalence

High SES

3.8

Low SES

37

High SES

14.6

Low SES

61.8

High SES

38.9

Low SES

77.6

Table 4. Factors associated with presence of HAV antibodies.
Factor

% seronegativity

P*

Relative
risk

Lower
limit

Upper
limit

High SES

Low SES

Parents income

71.4

32.3

<0.05

2.2

1.7

2.8

Source of water

70.5

28.3

<0.05

2.5

2.8

3.4

Residential area

66.9

30.2

<0.05

2.2

1.6

3.0

Parents level of education

72.7

20.0

<0.05

3.6

2.4

5.6

Crowded household

70.4

36.7

<0.05

1.9

1.5

2.4

Age

73.2

34.6

<0.05

3.8

2.8

5.8

P*: degree of significance.
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4. Discussion
The results of this study are in keeping with findings of previous studies [10] [11] [12]
that HAV antibody seropositivity increased significantly with advancing age and was
significantly different in every age group (P < 0.05). Our study indicates a significant
shift in the pattern of HAV epidemiology in Kenya. In previous findings it was observed that most African countries such as Kenya, had very high rates of HAV infection
and nearly all children by the age of 5 years had been infected [13]. The epidemiological
shift may be attributed to improved socioeconomic status, improved public sanitation,
use of chlorinated water and increased level of parental education. Hepatitis A virus
seroprevalence rate is directly related to socioeconomic development of a particular society. For example, in developed countries such as North American states, Austria and
Norway, seropositivity rates are low ranging from 2% and 20% in adolescence [14]. On
the contrary, seropositivity rates in developing countries range between 50% and 100%
until adult age and are related to poor socioeconomic development [15] [16] [17].
In deed when low and high socioeconomic status children are compared, the latter
tend to have a pattern close to those of developed countries while the former have similar patterns to those of developing nations (Table 5).
Results from the current study shows that disease acquisition among the high SES
population occurs in early adolescence and may proceed on to early adulthood rather
than in early childhood. This may coincide with young adults’ closer interaction at
school, involvement in risky behaviours such as poor hand hygiene and interacting
more and more with street populations [1] [2] [18]. The implication is that a low level
of HAV immunity among young adult population puts them at a higher risk of outbreaks and severer symptomatic infections [13] [19].
Table 5. The HAV antibody seroprevalence age groups in several countries.
Country

United Kingdom
(Das et al., 2000)

Italy (Fix et al., 2002)

India (Baudin et al., 1971)

Current study (Kenya)
Low SES High SES
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Age group (years)

HAV seroprevalence

5-9

10.5

10 - 14

13.9

15 - 19

19.6

3-5

2.3

17 - 19

16.3

6 - 10

62.2

11 - 15

68.5

Over 16

80.8

5-9

61.8

10 - 14

77.6

5-9

14.6

10 - 14

38.9
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This study reported a negative correlation between parental education level and
HAV antibody seroprevalence. This has also been observed in other previous studies
[17] [20]. It has been noted that parental education level has a direct effect on lifestyle
led by the family through influencing sanitation, living in a less crowded area and thus
being accessible to portable treated water [21]. On the contrary children from a low
SES, whose parental level of education was low, may have been exposed to negative environmental factors that facilitated hepatitis A transmission and hence infection.
Notable is that HAV vaccines that have been available just before the beginning of
the millennium providing consistent and long-lasting protection [22] have not been
fully utilized in our setting. Countries such as the United States where vaccination programs have been executed in high endemic areas have reported very low outbreaks of
HAV infections amongst young adults [9]. In Kenya, our national immunization program does not include HAV vaccine. We recommend that vaccination against HAV in
preschool-aged children and more so children from higher SES settings should be considered to mitigate future morbidity and mortality arising from HAV infection.

5. Conclusion and Recommendation
These results show a considerable rate of HAV antibody seronegativity amongst the
studied population especially those from richer backgrounds making them more susceptible to severe infection in future, with concomitant complications. We propose that
revision of National Vaccination Program should be considered to include Hepatitis A
vaccination.
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